GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Lepu Scientech Medical Technology (Shanghai) Co Ltd (HKSE:02291) » Definitions » Piotroski F-Score

Lepu Scientech Medical Technology (Shanghai) Co (HKSE:02291) Piotroski F-Score : 6 (As of Jun. 05, 2024)


View and export this data going back to 2022. Start your Free Trial

What is Lepu Scientech Medical Technology (Shanghai) Co Piotroski F-Score?

The zones of discrimination were as such:

Good or high score = 7, 8, 9
Bad or low score = 0, 1, 2, 3

Lepu Scientech Medical Technology (Shanghai) Co has an F-score of 6 indicating the company's financial situation is typical for a stable company.

The historical rank and industry rank for Lepu Scientech Medical Technology (Shanghai) Co's Piotroski F-Score or its related term are showing as below:

HKSE:02291' s Piotroski F-Score Range Over the Past 10 Years
Min: 5   Med: 5   Max: 6
Current: 6

During the past 5 years, the highest Piotroski F-Score of Lepu Scientech Medical Technology (Shanghai) Co was 6. The lowest was 5. And the median was 5.


Lepu Scientech Medical Technology (Shanghai) Co Piotroski F-Score Historical Data

The historical data trend for Lepu Scientech Medical Technology (Shanghai) Co's Piotroski F-Score can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Lepu Scientech Medical Technology (Shanghai) Co Piotroski F-Score Chart

Lepu Scientech Medical Technology (Shanghai) Co Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23
Piotroski F-Score
N/A N/A 5.00 5.00 6.00

Lepu Scientech Medical Technology (Shanghai) Co Semi-Annual Data
Dec19 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
Piotroski F-Score Get a 7-Day Free Trial 5.00 - 5.00 - 6.00

Competitive Comparison of Lepu Scientech Medical Technology (Shanghai) Co's Piotroski F-Score

For the Medical Devices subindustry, Lepu Scientech Medical Technology (Shanghai) Co's Piotroski F-Score, along with its competitors' market caps and Piotroski F-Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Lepu Scientech Medical Technology (Shanghai) Co's Piotroski F-Score Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Lepu Scientech Medical Technology (Shanghai) Co's Piotroski F-Score distribution charts can be found below:

* The bar in red indicates where Lepu Scientech Medical Technology (Shanghai) Co's Piotroski F-Score falls into.


How is the Piotroski F-Score calculated?

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

This Year (Dec23) TTM:Last Year (Dec22) TTM:
Net Income was HK$165.7 Mil.
Cash Flow from Operations was HK$179.7 Mil.
Revenue was HK$356.5 Mil.
Gross Profit was HK$315.9 Mil.
Average Total Assets from the begining of this year (Dec22)
to the end of this year (Dec23) was (2020.83 + 2172.755) / 2 = HK$2096.7925 Mil.
Total Assets at the begining of this year (Dec22) was HK$2,020.8 Mil.
Long-Term Debt & Capital Lease Obligation was HK$1.2 Mil.
Total Current Assets was HK$1,547.8 Mil.
Total Current Liabilities was HK$64.2 Mil.
Net Income was HK$-22.1 Mil.

Revenue was HK$276.6 Mil.
Gross Profit was HK$245.3 Mil.
Average Total Assets from the begining of last year (Dec21)
to the end of last year (Dec22) was (1371.024 + 2020.83) / 2 = HK$1695.927 Mil.
Total Assets at the begining of last year (Dec21) was HK$1,371.0 Mil.
Long-Term Debt & Capital Lease Obligation was HK$1.7 Mil.
Total Current Assets was HK$1,484.7 Mil.
Total Current Liabilities was HK$71.0 Mil.

*Note: If the latest quarterly/semi-annual/annual total assets data is 0, then we will use previous quarterly/semi-annual/annual data for all the items in the balance sheet.

Profitability

Question 1. Return on Assets (ROA)

Net income before extraordinary items for the year divided by Total Assets at the beginning of the year.

Score 1 if positive, 0 if negative.

Lepu Scientech Medical Technology (Shanghai) Co's current Net Income (TTM) was 165.7. ==> Positive ==> Score 1.

Question 2. Cash Flow Return on Assets (CFROA)

Net cash flow from operating activities (operating cash flow) divided by Total Assets at the beginning of the year.

Score 1 if positive, 0 if negative.

Lepu Scientech Medical Technology (Shanghai) Co's current Cash Flow from Operations (TTM) was 179.7. ==> Positive ==> Score 1.

Question 3. Change in Return on Assets

Compare this year's return on assets (1) to last year's return on assets.

Score 1 if it's higher, 0 if it's lower.

ROA (This Year)=Net Income/Total Assets (Dec22)
=165.743/2020.83
=0.08201729

ROA (Last Year)=Net Income/Total Assets (Dec21)
=-22.125/1371.024
=-0.01613757

Lepu Scientech Medical Technology (Shanghai) Co's return on assets of this year was 0.08201729. Lepu Scientech Medical Technology (Shanghai) Co's return on assets of last year was -0.01613757. ==> This year is higher. ==> Score 1.

Question 4. Quality of Earnings (Accrual)

Compare Cash flow return on assets (2) to return on assets (1)

Score 1 if CFROA > ROA, 0 if CFROA <= ROA.

Lepu Scientech Medical Technology (Shanghai) Co's current Net Income (TTM) was 165.7. Lepu Scientech Medical Technology (Shanghai) Co's current Cash Flow from Operations (TTM) was 179.7. ==> 179.7 > 165.7 ==> CFROA > ROA ==> Score 1.

Funding

Question 5. Change in Gearing or Leverage

Compare this year's gearing (long-term debt divided by average total assets) to last year's gearing.

Score 0 if this year's gearing is higher, 1 otherwise.

Gearing (This Year: Dec23)=Long-Term Debt & Capital Lease Obligation/Average Total Assets from Dec22 to Dec23
=1.202/2096.7925
=0.00057326

Gearing (Last Year: Dec22)=Long-Term Debt & Capital Lease Obligation/Average Total Assets from Dec21 to Dec22
=1.724/1695.927
=0.00101655

Lepu Scientech Medical Technology (Shanghai) Co's gearing of this year was 0.00057326. Lepu Scientech Medical Technology (Shanghai) Co's gearing of last year was 0.00101655. ==> This year is lower or equal to last year. ==> Score 1.

Question 6. Change in Working Capital (Liquidity)

Compare this year's current ratio (current assets divided by current liabilities) to last year's current ratio.

Score 1 if this year's current ratio is higher, 0 if it's lower

Current Ratio (This Year: Dec23)=Total Current Assets/Total Current Liabilities
=1547.775/64.197
=24.10977148

Current Ratio (Last Year: Dec22)=Total Current Assets/Total Current Liabilities
=1484.663/70.967
=20.92047008

Lepu Scientech Medical Technology (Shanghai) Co's current ratio of this year was 24.10977148. Lepu Scientech Medical Technology (Shanghai) Co's current ratio of last year was 20.92047008. ==> This year's current ratio is higher. ==> Score 1.

Question 7. Change in Shares in Issue

Compare the number of shares in issue this year, to the number in issue last year.

Score 0 if there is larger number of shares in issue this year, 1 otherwise.

Lepu Scientech Medical Technology (Shanghai) Co's number of shares in issue this year was 346.75. Lepu Scientech Medical Technology (Shanghai) Co's number of shares in issue last year was 327.556. ==> There is larger number of shares in issue this year. ==> Score 0.

Efficiency

Question 8. Change in Gross Margin

Compare this year's gross margin (Gross Profit divided by sales) to last year's.

Score 1 if this year's gross margin is higher, 0 if it's lower.

Gross Margin (This Year: TTM)=Gross Profit/Revenue
=315.895/356.458
=0.88620539

Gross Margin (Last Year: TTM)=Gross Profit/Revenue
=245.327/276.577
=0.88701157

Lepu Scientech Medical Technology (Shanghai) Co's gross margin of this year was 0.88620539. Lepu Scientech Medical Technology (Shanghai) Co's gross margin of last year was 0.88701157. ==> Last year's gross margin is higher ==> Score 0.

Question 9. Change in asset turnover

Compare this year's asset turnover (total sales for the year divided by total assets at the beginning of the year) to last year's asset turnover ratio.

Score 1 if this year's asset turnover ratio is higher, 0 if it's lower

Asset Turnover (This Year)=Revenue/Total Assets at the Beginning of This Year (Dec22)
=356.458/2020.83
=0.17639188

Asset Turnover (Last Year)=Revenue/Total Assets at the Beginning of Last Year (Dec21)
=276.577/1371.024
=0.20173024

Lepu Scientech Medical Technology (Shanghai) Co's asset turnover of this year was 0.17639188. Lepu Scientech Medical Technology (Shanghai) Co's asset turnover of last year was 0.20173024. ==> Last year's asset turnover is higher ==> Score 0.

Evaluation

Piotroski F-Score= Que. 1+ Que. 2+ Que. 3+Que. 4+Que. 5+Que. 6+Que. 7+Que. 8+Que. 9
=1+1+1+1+1+1+0+0+0
=6

Good or high score = 7, 8, 9
Bad or low score = 0, 1, 2, 3

Lepu Scientech Medical Technology (Shanghai) Co has an F-score of 6 indicating the company's financial situation is typical for a stable company.

Lepu Scientech Medical Technology (Shanghai) Co  (HKSE:02291) Piotroski F-Score Explanation

The developer of the system is Joseph D. Piotroski is relatively unknown accounting professor who shuns publicity and rarely gives interviews.

He graduated from the University of Illinois with a B.S. in accounting in 1989, received an M.B.A. from Indiana University in 1994. Five years later, in 1999, after earning a Ph.D. in accounting from the University of Michigan, he became an associate professor of accounting at the University of Chicago.

In 2000, he wrote a research paper called "Value Investing: The Use of Historical Financial Statement Information to Separate Winners from Losers" (pdf).

He wanted to see if he can develop a system (using a simple nine-point scoring system) that can increase the returns of a strategy of investing in low price to book (referred to in the paper as high book to market) value companies.

What he found was something that exceeded his most optimistic expectations.

Buying only those companies that scored highest (8 or 9) on his nine-point scale, or F-Score as he called it, over the 20 year period from 1976 to 1996 led to an average out-performance over the market of 13.4%.

Even more impressive were the results of a strategy of investing in the highest F-Score companies (8 or 9) and shorting companies with the lowest F-Score (0 or 1).

Over the same period from 1976 to 1996 (20 years) this strategy led to an average yearly return of 23%, substantially outperforming the average S&P 500 index return of 15.83% over the same period.


Lepu Scientech Medical Technology (Shanghai) Co Piotroski F-Score Related Terms

Thank you for viewing the detailed overview of Lepu Scientech Medical Technology (Shanghai) Co's Piotroski F-Score provided by GuruFocus.com. Please click on the following links to see related term pages.


Lepu Scientech Medical Technology (Shanghai) Co (HKSE:02291) Business Description

Traded in Other Exchanges
N/A
Address
No. 258, Xinzhuan Road, 1st Floor, 5th Floor Building 41, Songjiang District, Shanghai, CHN, 201612
Lepu Scientech Medical Technology (Shanghai) Co Ltd is focused on the research and development, production and marketing of structural heart disease medical interventional devices.
Executives
Pu Zhongjie 2201 Interest of corporation controlled by you
Le Pu Bei Jing Yi Liao Qi Xie Gu Fen You Xian Gong Si 2201 Interest of corporation controlled by you

Lepu Scientech Medical Technology (Shanghai) Co (HKSE:02291) Headlines

No Headlines